U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
Dr. Brite, LLC Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Mid America Pet Food LLC Center for Veterinary Medicine CGMP/Food for Animals/Prepared, Packed or Held Under Insanitary Conditions/Adulterated
Guangzhou Four E’s Scientific Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Knickerbocker 365 Inc. Office of Human & Animal Food Operations East 6 CGMP/Manufacturing, Packing or Holding Human Food/Adulterated/Insanitary Conditions
Purcell International Division of West Coast Imports Foreign Supplier Verification Program (FSVP)
WANABANA USA LLC Division of Southeast Imports Foreign Supplier Verification Program (FSVP)
Caribbean Produce Exchange, LLC Division of Southeast Imports Foreign Supplier Verification Program (FSVP)
MVRB2, LLC, d/b/a Kure CBD & Vape Center for Tobacco Products Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Applied Therapeutics, Inc. Center for Drug Evaluation and Research (CDER) Sponsor
Han C. Phan, M.D. Center for Drug Evaluation and Research (CDER) Clinical Investigator

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top